Merck Can't Escape Fosamax MDL, Patients Tell High Court
Patients suing Merck Sharp & Dohme Corp. over its alleged failure to warn about potential femoral fractures from its osteoporosis drug Fosamax have urged the Supreme Court to keep the multidistrict...To view the full article, register now.
Already a subscriber? Click here to view full article